-

e.l.f. Beauty, Inc. (ELF) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of e.l.f. Beauty, Inc. (“Elf” or the “Company”) (NYSE: ELF) investors concerning the Company’s possible violations of federal securities laws.

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN E.L.F. BEAUTY, INC. (ELF), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.

Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@howardsmithlaw.com, by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com.

What Happened?

On November 20, 2024, Muddy Waters Research published a report alleging, among other things, that Elf had “materially overstated revenue over the past three quarters,” and that, in the second quarter of 2024, the Company “began reporting inflated revenue and profits” as well as inventory “to account for cash that has not really come in.”

On this news, Elf’s stock price fell $2.71, or 2.2%, to close at $119.00 per share on November 20, 2024, thereby injuring investors.

Contact Us To Participate or Learn More:

If you purchased Elf securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:

Law Offices of Howard G. Smith
3070 Bristol Pike, Suite 112
Bensalem, Pennsylvania 19020
Telephone: (215) 638-4847
Email: howardsmith@howardsmithlaw.com
Visit our website at: www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

Law Offices of Howard G. Smith

NYSE:ELF

Release Versions

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

More News From Law Offices of Howard G. Smith

Law Offices of Howard G. Smith Encourages Millrose Properties, Inc. (MRP) Shareholders To Inquire About Securities Fraud Class Action

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Millrose Properties, Inc. (“Millrose” or the “Company”) (NYSE: MRP) common stock between February 7, 2025 and October 2, 2026, inclusive (the “Class Period”). Millrose Properties, Inc. investors have until December 8, 2026 to file a lead plaintiff motion.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN MILLROSE PROPERTIES, INC. (MRP), CONTACT THE L...

Law Offices of Howard G. Smith Encourages Duolingo, Inc. (DUOL) Shareholders To Inquire About Securities Fraud Class Action

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased acquired Duolingo, Inc. (“Duolingo” or the “Company”) (NASDAQ: DUOL) common stock between May 2, 2025 and February 26, 2026, inclusive (the “Class Period”). Duolingo investors have until December 7, 2026 to file a lead plaintiff motion.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN DUOLINGO, INC. (DUOL), CONTACT THE LAW OFFICES OF HOWARD G. SMITH...

Law Offices of Howard G. Smith Announces Investigation of Universe Pharmaceuticals INC. (UPC) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces it is investigating potential claims against the board of directors of Universe Pharmaceuticals INC. ("Universe Pharmaceuticals" or the "Company") (NASDAQ: UPC) concerning whether the board breached its fiduciary duties to shareholders. IF YOU ARE A UNIVERSE PHARMACEUTICALS INC. (UPC) SHAREHOLDER, CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE. Contact Us To Participate or Learn More: If you still hold Universe...
Back to Newsroom